Becker Capital Management Inc Bristol Myers Squibb CO Transaction History

Becker Capital Management Inc

  • $3.04 Billion
  • Q3 2024

A detailed history of Becker Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Becker Capital Management Inc holds 6,912 shares of BMY stock, worth $399,237. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,912
Previous 6,087 13.55%
Holding current value
$399,237
Previous $252,000 41.67%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$39.66 - $51.75 $32,719 - $42,693
825 Added 13.55%
6,912 $357,000
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $2,399 - $2,720
-50 Reduced 0.81%
6,087 $330,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $18,325 - $21,867
-378 Reduced 5.8%
6,137 $314,000
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $11,288 - $12,622
195 Added 3.09%
6,515 $378,000
Q2 2023

Aug 11, 2023
SELL
$63.71 - $70.74 $58,039 - $64,444
-911 Reduced 12.6%
6,320 $404,000
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $23,655 - $26,830
360 Added 5.24%
7,231 $501,000
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $65 - $38,727
504 Added 7.92%
6,871 $488,000
Q1 2022

May 12, 2022
SELL
$61.48 - $73.72 $368 - $442
-6 Reduced 0.09%
6,367 $465,000
Q4 2021

Feb 08, 2022
BUY
$53.63 - $62.52 $52,450 - $61,144
978 Added 18.13%
6,373 $397,000
Q3 2021

Oct 14, 2021
SELL
$59.17 - $69.31 $9,822 - $11,505
-166 Reduced 2.99%
5,395 $319,000
Q1 2021

May 13, 2021
BUY
$59.34 - $66.74 $35,604 - $40,044
600 Added 12.09%
5,561 $351,000
Q4 2020

Feb 10, 2021
BUY
$57.74 - $65.43 $90,940 - $103,052
1,575 Added 46.52%
4,961 $308,000
Q3 2020

Nov 09, 2020
BUY
$57.43 - $63.64 $194,457 - $215,485
3,386 New
3,386 $204,000
Q1 2020

May 07, 2020
SELL
$46.4 - $67.43 $159,152 - $231,284
-3,430 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$49.21 - $64.19 $168,790 - $220,171
3,430 New
3,430 $220,000
Q2 2019

Aug 08, 2019
SELL
$44.62 - $49.34 $351,962 - $389,193
-7,888 Closed
0 $0
Q4 2018

Feb 04, 2019
SELL
$48.76 - $63.23 $55,586 - $72,082
-1,140 Reduced 12.63%
7,888 $410,000
Q3 2018

Nov 05, 2018
BUY
$55.19 - $62.25 $110,380 - $124,500
2,000 Added 28.46%
9,028 $560,000
Q1 2018

May 07, 2018
BUY
$59.92 - $68.98 $11,205 - $12,899
187 Added 2.73%
7,028 $445,000
Q4 2017

Feb 13, 2018
BUY
$59.94 - $65.35 $410,049 - $447,059
6,841
6,841 $419,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email